Basic information
Biomarker: p21
Biomarker subtype: gene
Clinical application: prognosis(favorable)
Histology type: endometrioid endometrial carcinoma
Cohort characteristics
Country: Japan
Region: Sendai
Study type: retrospective study
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 75 | endometrial carcinoma | 75 |
Sample information
Sample type : tissue
Clinical method: PCR-SSCP
Expression pattern : expression
Expression elevation: Immunostained slides were evaluated according to both the intensity of staining and the number of positive tumour cells as follows:3 tumours were classified as strongly positive when nuclear immunoreactivity was intense and/or positive cells accounted for more than 10 per cent of tumour cells; as weakly focally positive when nuclear immunoreactivity was weak and/or positive cells accounted for less than 10 per cent of tumour cells; and as negative when there was no reactivity.
Disease information
Related information
Description: p21 expression were considered as prognostic indicators in patients with endometrioid endometrial carcinoma.
